Cargando…

Costs related to immunopreventable diseases: Brazil and its geographic areas (immunopreventable diseases’ costs in Brazil)

INTRODUCTION: The occurrence of the immunopreventable diseases in a population global reality. OBJECTIVE: To discriminate the direct costs of the hospitalizations from the immunopreventable diseases in the Unified Health System (SUS), in Brazil and their areas, between 2008 and 2018. METHODS: A popu...

Descripción completa

Detalles Bibliográficos
Autores principales: da Costa, Élide Sbardellotto M., Hyeda, Adriano, Maluf, Eliane M. C. P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555006/
https://www.ncbi.nlm.nih.gov/pubmed/34706728
http://dx.doi.org/10.1186/s12913-021-07117-5
_version_ 1784591893531721728
author da Costa, Élide Sbardellotto M.
Hyeda, Adriano
Maluf, Eliane M. C. P.
author_facet da Costa, Élide Sbardellotto M.
Hyeda, Adriano
Maluf, Eliane M. C. P.
author_sort da Costa, Élide Sbardellotto M.
collection PubMed
description INTRODUCTION: The occurrence of the immunopreventable diseases in a population global reality. OBJECTIVE: To discriminate the direct costs of the hospitalizations from the immunopreventable diseases in the Unified Health System (SUS), in Brazil and their areas, between 2008 and 2018. METHODS: A population, observational, descriptive and retrospective study, with data from the information supplied by the DATASUS website, these data were collected during the 2019. RESULTS: It was identified 457,479 hospitalizations in the period; with a total of 2,450,870 days of hospital stay, with total costs of R$389,243,264.85. Only the disease mumps presented a growing tendency in whole areas; the chickenpox was decreasing; the illness whooping cough, yellow fever and tetanus were stationary in this period. CONCLUSIONS: The costs related to immunopreventable diseases were relevant in all the Brazil areas, with tendencies different between the geographic areas and between the several illnesses analysed.
format Online
Article
Text
id pubmed-8555006
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-85550062021-10-29 Costs related to immunopreventable diseases: Brazil and its geographic areas (immunopreventable diseases’ costs in Brazil) da Costa, Élide Sbardellotto M. Hyeda, Adriano Maluf, Eliane M. C. P. BMC Health Serv Res Research INTRODUCTION: The occurrence of the immunopreventable diseases in a population global reality. OBJECTIVE: To discriminate the direct costs of the hospitalizations from the immunopreventable diseases in the Unified Health System (SUS), in Brazil and their areas, between 2008 and 2018. METHODS: A population, observational, descriptive and retrospective study, with data from the information supplied by the DATASUS website, these data were collected during the 2019. RESULTS: It was identified 457,479 hospitalizations in the period; with a total of 2,450,870 days of hospital stay, with total costs of R$389,243,264.85. Only the disease mumps presented a growing tendency in whole areas; the chickenpox was decreasing; the illness whooping cough, yellow fever and tetanus were stationary in this period. CONCLUSIONS: The costs related to immunopreventable diseases were relevant in all the Brazil areas, with tendencies different between the geographic areas and between the several illnesses analysed. BioMed Central 2021-10-27 /pmc/articles/PMC8555006/ /pubmed/34706728 http://dx.doi.org/10.1186/s12913-021-07117-5 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
da Costa, Élide Sbardellotto M.
Hyeda, Adriano
Maluf, Eliane M. C. P.
Costs related to immunopreventable diseases: Brazil and its geographic areas (immunopreventable diseases’ costs in Brazil)
title Costs related to immunopreventable diseases: Brazil and its geographic areas (immunopreventable diseases’ costs in Brazil)
title_full Costs related to immunopreventable diseases: Brazil and its geographic areas (immunopreventable diseases’ costs in Brazil)
title_fullStr Costs related to immunopreventable diseases: Brazil and its geographic areas (immunopreventable diseases’ costs in Brazil)
title_full_unstemmed Costs related to immunopreventable diseases: Brazil and its geographic areas (immunopreventable diseases’ costs in Brazil)
title_short Costs related to immunopreventable diseases: Brazil and its geographic areas (immunopreventable diseases’ costs in Brazil)
title_sort costs related to immunopreventable diseases: brazil and its geographic areas (immunopreventable diseases’ costs in brazil)
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555006/
https://www.ncbi.nlm.nih.gov/pubmed/34706728
http://dx.doi.org/10.1186/s12913-021-07117-5
work_keys_str_mv AT dacostaelidesbardellottom costsrelatedtoimmunopreventablediseasesbrazilanditsgeographicareasimmunopreventablediseasescostsinbrazil
AT hyedaadriano costsrelatedtoimmunopreventablediseasesbrazilanditsgeographicareasimmunopreventablediseasescostsinbrazil
AT malufelianemcp costsrelatedtoimmunopreventablediseasesbrazilanditsgeographicareasimmunopreventablediseasescostsinbrazil